Vardhaman Patel

10PUBLICATIONS
23CO-AUTHORS
Gene and molecular therapyRheumatology and arthritisPharmacogenomicsEpidemiological methodsSite-based writing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 03, 2024
The Association Between Patient-Reported Disease Burden and Treatment Switching in Patients with Plaque Psoriasis Treated with Nonbiologic Systemic Therapy.

Vardhaman Patel, Sang Hee Park, Yichen Zhong

|Nov 18, 2024
Real-world clinical outcomes and rationale for initiating abatacept as a first-line biologic for patients with anticitrullinated protein antibody- and rheumatoid factor-positive rheumatoid arthritis.

Alexandrina Balanean, Cherrishe Brown-Bickerstaff, Andrew Klink

|Jun 24, 2024
Cost per response analysis of deucravacitinib versus apremilast and first-line biologics among patients with moderate to severe plaque psoriasis in the United States.

Sang Hee Park, Mark Lambton, Jordana Schmier

|Jun 24, 2024
Evaluating prevalence and consequence of residual disease in individuals with psoriasis receiving apremilast treatment: results from a US patient survey.

Tina Bhutani, Sayeli Jayade, Sanika Rege

|Jun 22, 2024
Cumulative Benefit Over 52 Weeks With Deucravacitinib Versus Apremilast in Moderate to Severe Plaque Psoriasis: POETYK PSO-1 Post Hoc Analysis.

April W Armstrong, Sang Hee Park, Vardhaman Patel

|Jan 22, 2024
Evaluating Treatment Choice in Patients with Moderate to Severe Psoriasis in the United States: Results from a US Patient Survey.

April W Armstrong, Sayeli Jayade, Sanika Rege

Pageof 2

Frequent Collaborators

5 joint publications

Sang Hee Park

4 joint publications

April W Armstrong

3 joint publications

Lauren Seigel

3 joint publications

Wei-Jhih Wang